title: Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer.
authors.affiliation: Department of Urology and Roland and Ruby Holden Cancer Research Laboratories, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52242, USA. david-lubaroff@uiowa.edu
authors.forename: David M
authors.initials: DM
authors.lastname: Lubaroff
authors.forename: Badrinath
authors.initials: B
authors.lastname: Konety
authors.forename: Brian K
authors.initials: BK
authors.lastname: Link
authors.forename: Timothy L
authors.initials: TL
authors.lastname: Ratliff
authors.forename: Tammy
authors.initials: T
authors.lastname: Madsen
authors.forename: Mary
authors.initials: M
authors.lastname: Shannon
authors.forename: Dixie
authors.initials: D
authors.lastname: Ecklund
authors.forename: Richard D
authors.initials: RD
authors.lastname: Williams
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D019496:Cancer Vaccines / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use*; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D004306:Dose-Response Relationship, Immunologic; D005781:Gelatin Sponge, Absorbable; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D008297:Male; D018579:Patient Selection; D017430:Prostate-Specific Antigen / Q000235:genetics* / Q000276:immunology; D011471:Prostatic Neoplasms / Q000276:immunology / Q000473:pathology* / Q000628:therapy*
chemical_list: D019496:Cancer Vaccines; D017430:Prostate-Specific Antigen